BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 6502004)

  • 1. Opsonic activity of immunoglobulin prepared for intravenous use.
    Hetherington SV; Giebink GS
    J Lab Clin Med; 1984 Dec; 104(6):977-86. PubMed ID: 6502004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opsonic activity of a new intravenous immunoglobulin preparation: Pentaglobin compared with sandoglobulin.
    Garbett ND; Munro CS; Cole PJ
    Clin Exp Immunol; 1989 Apr; 76(1):8-12. PubMed ID: 2500275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.
    Verhoef J; Peterson P; Kim Y; Sabath LD; Quie PG
    Immunology; 1977 Aug; 33(2):191-7. PubMed ID: 415969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased serum opsonic activity against Streptococcus pneumoniae in human immunodeficiency virus-infected Ugandan adults.
    Takahashi H; Oishi K; Yoshimine H; Kumatori A; Moji K; Watanabe K; Nalwoga H; Tugume SB; Kebba A; Mugerwa R; Mugyenyi P; Nagatake T
    Clin Infect Dis; 2003 Dec; 37(11):1534-40. PubMed ID: 14614677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirements for the opsonic activity of human IgG directed to type 6 group A streptococci: net basic charge and intact Fc region.
    Fischetti VA
    J Immunol; 1983 Feb; 130(2):896-902. PubMed ID: 6336773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of antibody activity against various microorganisms in intravenous immunoglobulin preparations determined by ELISA and opsonic assay.
    Hiemstra PS; Brands-Tajouiti J; van Furth R
    J Lab Clin Med; 1994 Feb; 123(2):241-6. PubMed ID: 8301200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum opsonic deficiency produced by Streptococcus pneumoniae and by capsular polysaccharide antigens.
    Giebink GS; Grebner JV; Kim Y; Quie PG
    Yale J Biol Med; 1978; 51(5):527-38. PubMed ID: 34937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody inhibition of polymorphonuclear phagocytosis. Dissociation of bacterial attachment and bacterial killing.
    Crowley JP; Valeri CR
    J Lab Clin Med; 1980 Jun; 95(6):868-76. PubMed ID: 7381296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.
    Verbrugh HA; Peterson PK; Nguyen BY; Sisson SP; Kim Y
    J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative opsonic activity of intravenous gamma globulin preparations for common bacterial pathogens.
    Hill HR; Augustine NH; Shigeoka AO
    Am J Med; 1984 Mar; 76(3A):61-6. PubMed ID: 6424458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opsonins in human serum for the phagocytosis of complexes between IgG and protein A of Staphylococcus aureus.
    Hällgren R; Stålenheim G
    Immunology; 1978 Jul; 35(1):13-20. PubMed ID: 680797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas respiratory infection in cystic fibrosis: a possible defect in opsonic IgG antibody?
    Fick RB; Reynolds HY
    Bull Eur Physiopathol Respir; 1983; 19(2):151-61. PubMed ID: 6871494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovine opsonins for Staphylococcus aureus cell wall and pseudocapsule.
    Watson DL
    Res Vet Sci; 1989 Jan; 46(1):84-9. PubMed ID: 2784216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opsonic activity of human IgG and IgM antibody for type III group B streptococci.
    Anthony BF; Concepcion NF
    Pediatr Res; 1989 Oct; 26(4):383-7. PubMed ID: 2677951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phagocytosis by human alveolar macrophages and neutrophils: qualitative differences in the opsonic requirements for uptake of Staphylococcus aureus and Streptococcus pneumoniae in vitro.
    Hof DG; Repine JE; Peterson PK; Hoidal JR
    Am Rev Respir Dis; 1980 Jan; 121(1):65-71. PubMed ID: 7352714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiencies in opsonic defense to pneumococci in the human newborn despite adequate levels of complement and specific IgG antibodies.
    Geelen SP; Fleer A; Bezemer AC; Gerards LJ; Rijkers GT; Verhoef J
    Pediatr Res; 1990 May; 27(5):514-8. PubMed ID: 2345679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum opsonic activity in rodent malaria: functional and immunochemical characteristics in vitro.
    Hunter KW; Winkelstein JA; Simpson TW
    J Immunol; 1979 Dec; 123(6):2582-7. PubMed ID: 387873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opsonization of Staphylococcus aureus by bovine immunoglobulin isotypes.
    Guidry AJ; Berning LM; Hambleton CN
    J Dairy Sci; 1993 May; 76(5):1285-9. PubMed ID: 8505420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of immune globulin intravenous on opsonization of bacteria by classic and alternative complement pathways in premature serum.
    Shaio MF; Yang KD; Bohnsack JF; Hill HR
    Pediatr Res; 1989 Jun; 25(6):634-40. PubMed ID: 2662129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro effect of intravenous immunoglobulin supplementation on serum opsonic activity in tracheostomised patients.
    Chandra RS; Dandekar UP; Karnard D; Tilve GH; Kshirsagar NA
    Indian J Med Res; 1992 Apr; 96():109-11. PubMed ID: 1428049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.